USA-based Kailera Therapeutics today announced its launch as a clinical-stage biopharmaceutical company focused on advancing ...

Roche sees significant potential in the growing obesity market, estimating it could exceed $100 billion by 2030. During its ...

Johnson & Johnson has halted its plan to implement a 340B rebate model after the Health Resources and Services Administration ...

Following a positive a positive European Medicines Agency recommendation in July, the European Commission (EC) has now ...

Bristol Myers Squibb won a legal victory as a New York judge dismissed a $6.4 billion lawsuit filed by UMB Bank on behalf of ...

ARS Pharmaceuticals' Neffy, the first needle-free epinephrine nasal spray, is poised to significantly impact the treatment of ...

The Russian government has finalized the rules for granting preference to domestic drugs in public procurements, which will ...

Nxera Pharma has entered a new commercial partnership agreement with fellow Japanese drugmaker Shionogi regarding the ...

Germany-headquartered CNS drug specialist Neuraxpharm Group today announced the launch of Neuraxpharm Middle East to cover ...

Recipharm and Exela Pharma Sciences have formed an exclusive strategic alliance to expand sterile manufacturing capabilities ...

Rivus Pharmaceuticals announced new Phase IIa HuMAIN study data for HU6, its investigational treatment for obesity-related ...

AstronauTx, a biotech developing novel treatments for Alzheimer's disease and other neurodegenerative disorders, has ...